F-Prime Capital

F-Prime Capital is a global venture capital firm investing in healthcare and technology sectors. The firm focuses on early-stage investments in therapeutics, medtech, healthtech, enterprise software, fintech, frontier tech, and crypto. With over $5.3 billion in assets under management, F-Prime has backed more than 370 companies globally, including over 30 that were started from scratch. Their portfolio includes companies such as Inflammatix, Denali Therapeutics, Repare Therapeutics, and ThoughtSpot. F-Prime's approach combines financial support with strategic guidance and operational assistance to help companies achieve scalable growth. The firm's seasoned team comprises scientists, engineers, physicians, operators, and investors, bringing real-world expertise to their partnerships. F-Prime's roots trace back to Fidelity Investments, founded in 1946, evolving from Fidelity Ventures into an independent subsidiary. Their investment philosophy emphasizes a long-term approach, partnering with entrepreneurs to build innovative companies. The firm has a history of successful exits, with 49 IPOs among its portfolio companies. F-Prime's diverse portfolio spans various sectors, including artificial intelligence, biopharmaceuticals, blockchain, digital media, edtech, enterprise IT, fintech, healthcare IT, healthcare services, internet of things, life sciences, manufacturing, medical devices, mobile, real estate, robotics, software, and transportation. Their investment stages range from seed to late-stage ventures, supporting companies at various growth phases. The firm's strategic guidance and operational support aim to help companies achieve their growth objectives and make a significant impact in their respective industries.

Innovative solutions in healthcare and technology sectors, Strong management teams, Scalable business models, Potential for significant impact in respective industries